Sign up to save your podcasts
Or
Share Thursday, October 19, 2023
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Thursday, October 19, 2023
CMS has removed amyloid PET scan restrictions for Medicare beneficiaries. Novo Nordisk stops its Ozempic trial for treating kidney failure following early signs of the drug’s success. And, a new study finds that healthcare providers continue to leave the field in droves. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By Gist Healthcare Daily
4.8
134134 ratings
CMS has removed amyloid PET scan restrictions for Medicare beneficiaries. Novo Nordisk stops its Ozempic trial for treating kidney failure following early signs of the drug’s success. And, a new study finds that healthcare providers continue to leave the field in droves. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
More shows like The Gist Healthcare Podcast
View all
Marketplace Tech
1,277 Listeners
Marketplace Morning Report
873 Listeners
WSJ Your Money Briefing
1,757 Listeners
Marketplace
8,582 Listeners
Marketplace All-in-One
1,357 Listeners
POLITICO Playbook Daily Briefing
634 Listeners
The Daily
111,530 Listeners
Up First from NPR
56,169 Listeners
Bold Names
1,433 Listeners
KFF Health News' 'What the Health?'
468 Listeners
An Arm and a Leg
1,077 Listeners
Becker’s Healthcare Podcast
177 Listeners
Tradeoffs
390 Listeners
Consider This from NPR
5,972 Listeners
Raising Health
141 Listeners